BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+47.9%
5Y CAGR+121.2%
Year-over-Year Change
Revenue minus cost of goods sold
3Y CAGR
+47.9%/yr
vs +90.2%/yr prior
5Y CAGR
+121.2%/yr
Recent deceleration
Acceleration
-42.3pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
53x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $855.03M | +95.1% |
| 2024 | $438.23M | +34.1% |
| 2023 | $326.75M | +23.7% |
| 2022 | $264.23M | +76.3% |
| 2021 | $149.91M | +829.0% |
| 2020 | $16.14M | -63.9% |
| 2019 | $44.73M | +121.7% |
| 2018 | $20.18M | -14.1% |
| 2017 | $23.48M | -0.7% |
| 2016 | $23.65M | - |